참고문헌
- Baird D, Dunson DB (2003). Why is parity protective for uterine fibroids? Epidemiol, 14, 247-50.
- Briet JM, Hollema H, Reesink N, et al (2005). Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol, 96, 799-4. https://doi.org/10.1016/j.ygyno.2004.11.033
- Brinton LA, Westwoff CL, Scoccia B, et al (2013). Fertility drugs and endometrial cancer risk: results from an extended followup of a large infertility cohort. Hum Reprod, 28, 2813-21. https://doi.org/10.1093/humrep/det323
- Dos Reis R, Burzawa JK, Tsunoda AT, et al (2015). Lymphovascular space invasion portends poor prognosis in low-risk endometrial cancer. Int J Gynecol Cancer, 25, 1292-99. https://doi.org/10.1097/IGC.0000000000000490
- Dossus L, Allen N, Kaaks R, et al (2010). Reproductive risk factors and endometrial cancer: The European Prospective Investigation into Cancer and Nutrition. Int J Gynecol Cancer, 127, 442-51.
- Emons G, Fleckensteins G, Hinney B, Huschmand A, Heyl W (2000). Hormonal interactions in endometrial cancer. Endocr Relat Cancer, 7, 227-42. https://doi.org/10.1677/erc.0.0070227
- Fauziah M, Hamizah M, Norazmi A, Lila P (2006). Report no. 1/2006. Kota Bharu: Kelantan Health State Department, 1999-2003.
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-17. https://doi.org/10.1002/ijc.25516
- Friberg E, Mantzoros CS, Wolk A (2007). Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev, 16, 276-80. https://doi.org/10.1158/1055-9965.EPI-06-0751
- Henderson BE, Feigelson HS (2000). Hormonal carcinogenesis. Carcinogenesis, 21, 427-33. https://doi.org/10.1093/carcin/21.3.427
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al (2011). Global cancer statistics. CA Cancer J Clin, 69, 69-90.
- Jones ME, Van Leeuwen FE, Hoogendoorn WE, et al (2012). Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries. Breast Cancer Res, 14, 91. https://doi.org/10.1186/bcr3206
- Karageorgi S, Hankinson SE, Kraft P, De Vivo I (2010). Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004. Int J Cancer, 126, 208-16. https://doi.org/10.1002/ijc.24672
- Kashima H, Shiozawa T, Miyamoto T, et al (2009). Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogenactivated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E. Endocr Relat Cancer, 16, 113-22.
- Kaupilla A, Gronroos M, Nieminen U (1982). Clinical outcome in endometrial cancer. Obstet Gynecol, 60, 473-80.
- Lindemann K, Vatten LJ, Ellstrom-Engh M, Eskild A (2008). Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer, 98, 1582-85. https://doi.org/10.1038/sj.bjc.6604313
- Lopez-Bermejo A, Khosravi J, Fernandez-Real JM, et al (2006). Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25). Diabetes, 55, 2333-39. https://doi.org/10.2337/db05-1627
- Mannelqvist M, Sefanson IM, Bredholt G, et al (2011). Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer. Am J Pathol, 178, 861-71. https://doi.org/10.1016/j.ajpath.2010.10.040
- Mendivil A, Schuler KM, Gehrig PA (2009). Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. Cancer Control, 16, 46-52. https://doi.org/10.1177/107327480901600107
- Pavelic J, Radakovic B, Pavelic K (2007). Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma. Gynecol Oncol, 105, 727-35. https://doi.org/10.1016/j.ygyno.2007.02.012
- Renehan AG, Zwahlen M, Minder C, et al (2004). Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet, 363, 1346-53. https://doi.org/10.1016/S0140-6736(04)16044-3
- Schonfeld SJ, Hartge P, Pfeiffer RM, et al (2013). An aggregated analysis of hormonal factors and endometrial cancer risk by parity. Cancer, 119, 1393-99. https://doi.org/10.1002/cncr.27909
- Yu H & Rohan T (2000). Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst, 92, 1472-89. https://doi.org/10.1093/jnci/92.18.1472
- Zainal Ariffin O, Nor Saleha I (2011). National Cancer Registry Report 2007. Malaysia: Ministry of Health.
- Zaorsky NG, Patil N, Freedman GM, Tuluc M (2012). Differentiating lymphovascular invasion from retraction artifact on histological specimen of breast carcinoma and their implications on prognosis. J Breast Cancer, 15, 478-80. https://doi.org/10.4048/jbc.2012.15.4.478